FIELD: medicine.
SUBSTANCE: invention refers to medicine and is intended to specify a stage of hepatic fibrosis in clinical-laboratory conditions. Determined protein products are represented by cytokines CXCL11/ITAC, TNFα and CCL20/MIP-3α. Their concentration in blood plasma and conformity marker concentration threshold values enables diagnosing degree of hepatic fibrosis. Threshold values for differential diagnosis of F1 and F2: CXCL11/ITAC - 166.5 pg/mL, TNFα - 15.7 pg/mL, CCL20/MIP-3α - 10.6 pg/mL; for differential diagnosis of F2 and F3: TNFα - 15.8 pg/mL, CXCL11/ITAC - 301.8 pg/mL, CCL20/MIP-3α - 15.5 pg/mL.
EFFECT: method reduces number of measured values with simultaneous increase of sensitivity of method to 67-91 % and maintaining required specificity.
1 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIATING HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIS B AND AUTOIMMUNE LIVER INJURIES | 2018 |
|
RU2701723C1 |
| METHOD FOR DIAGNOSTICS OF SEVERE LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C WITH GENOTYPE 1 | 2017 |
|
RU2639480C1 |
| METHOD FOR DIFFERENTIATING CAUSES OF DEVELOPMENT OF INITIAL STAGE OF HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIDES B AND C | 2019 |
|
RU2759672C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS B, CHRONIC HEPATITIS C AND AUTOIMMUNE LIVER DISEASES IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2834902C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS B AND CHRONIC HEPATITIS C IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2835987C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS B AND AUTOIMMUNE LIVER DISEASES IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2834900C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS C AND AUTOIMMUNE LIVER DISEASES IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2834898C1 |
| DIAGNOSTIC TECHNIQUE FOR RHEUMATOID ARTHRITIS | 2014 |
|
RU2554755C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC FIBROSIS ACCOMPANYING VIRAL HEPATITIS C | 2014 |
|
RU2557927C1 |
| METHOD OF HEPATIC FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C | 2009 |
|
RU2416794C1 |
